EyeGene Inc. (KOSDAQ:185490)
South Korea
· Delayed Price · Currency is KRW 2,720.00
+210.00 (8.37%)
At close: Mar 28, 2025, 3:30 PM KST
EyeGene Revenue
In the year 2024, EyeGene had annual revenue of 3.36B KRW with 7.37% growth. EyeGene had revenue of 1.31B in the quarter ending December 31, 2024, with 8.07% growth.
Revenue
3.36B
Revenue Growth
+7.37%
P/S Ratio
22.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
74.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |